+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Inhaled And Intranasal Products Contract Service Providers Market Size, Share & Trends Analysis Report By Drug Delivery Product (Metered-dose inhalers, Dry powder inhalers, Nebulizers), By Services, By Region And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 275 Pages
  • November 2022
  • Region: Global
  • Grand View Research
  • ID: 5702106
Description Jump to:
The global inhaled and intranasal products contract service providers market size is estimated to reach USD 4.5 billion by 2030., expanding at a CAGR of 8.5% from 2023 to 2030. There is an increased awareness of the effective and advanced respiratory devices compared to the traditional treatments fueling the growth of the market.

Inhaler design has seen little change in the past ten years, but some features have led to advancements that open new possibilities for disease treatment according to an article published by the National Library of Medicine (NIH) in 2021. The development of vibrating mesh systems for nebulizers was the most significant advancement, whereas the formulation, metering system, and aerosol dispersion properties are the three main components of dry powder inhaler technology. Furthermore, one of the most important breakthroughs at the start of the new millennium was the regulatory approval and commercialization of Advair/Seretide (GlaxoSmithKline). These developments and advancements in the design of the product improve the drug delivery system. Hence, contributing to the growth of the inhaled & intranasal products contract service providers market.

COVID-19 has resulted in a positive impact on the market. For instance, according to a July 2020 article titled "Inhalers Safe During COVID-19 Pandemic," asthma and chronic obstructive pulmonary disease patients are usually prescribed inhaled and oral corticosteroids along with inhalers to avoid attacks. Inhaler shortages occurred in the U.K. as a result of a 400% increase in demand during the pandemic. The U.K.’s population was attempting to stock up in anticipation of the COVID-19 pandemic, according to the Department of Health and Social Care, which resulted in distressing shortages. As a result, during the pandemic phase, such incidences increased the demand for the market.

Inhaled And Intranasal Products Contract Service Providers Market Report Highlights

  • Metered- dose inhalers (MDIs) segment dominated the market with a revenue share of 50.6% in 2022. This is due to the rise in their ease of use, which is often self-administered by the patient through inhalation in short bursts of a predetermined dose
  • Based on services, contract manufacturing dominated the segment with a revenue share of 54.8% in 2022. The increasing focus of manufacturers on reducing the cost of medical devices drives the growth of the market
  • Quality assurance services is anticipated to register the fastest CAGR growth of 10.8% during the forecast period
  • Asia Pacific dominated the market in 2022 with a 41.7% market share. The presence of a large number of contract manufacturers, and increasing respiratory diseases such as COPD are the key factors driving the growth of the market

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Drug Delivery Product
1.1.2. Services
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Volume price analysis (Model 2)
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
1.9.3. Objective 3
1.9.4. Objective 4
Chapter 2. Executive Summary
2.1. Market Outlook
Chapter 3. Inhaled and Intranasal Products Contract Service Providers Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising prevalence of chronic diseases such as COPD, increasing prevalence of diabetes
3.2.1.2. Rise in geriatric population
3.2.1.3. Increase in technological advancement w.r.t to product offerings
3.2.2. Market restraint analysis
3.2.2.1. Stringent Government Regulations for the Product Approval
3.2.3. Covid-19 Impact & Recovery Analysis
3.2.4. Heat Map Analysis
3.2.5. Major Deals and Strategic Alliances Analysis
3.2.6. Industry Analysis - Porter’s
3.2.7. PESTLE Analysis
Chapter 4. Inhaled and Intranasal Products Contract Service Providers Market: Drug Delivery Product Segment Analysis
4.1. Inhaled and Intranasal Products Contract Service Providers Market: Definition & Scope
4.2. Inhaled and Intranasal Products Contract Service Providers Market: Drug Delivery Product Market Share Analysis, 2022 & 2030
4.2.1. Metered- dose Inhalers
4.2.1.1. Metered- dose Inhalers Market, 2018 - 2030 (USD Million)
4.2.2. Dry Powder Inhalers
4.2.2.1. Dry Powder Inhalers Market, 2018 - 2030 (USD Million)
4.2.3. Nebulizers
4.2.3.1. Nebulizers Market, 2018 - 2030 (USD Million)
4.2.4. Others
4.2.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Inhaled and Intranasal Products Contract Service Providers Market: Services Segment Analysis
5.1. Inhaled and Intranasal Products Contract Service Providers Market: Definition & Scope
5.2. Inhaled and Intranasal Products Contract Service Providers Market: Services Market Share Analysis, 2022 & 2030
5.2.1. Quality Assurance
5.2.1.1. Quality Assurance Market, 2018 - 2030 (USD Million)
5.2.2. Regulatory Affairs Services
5.2.2.1. Regulatory Affairs Services Market, 2018 - 2030 (USD Million)
5.2.3. Product Design & Development
5.2.3.1. Product Design & Development Market, 2018 - 2030 (USD Million)
5.2.4. Product Testing & Sterilization
5.2.4.1. Product Testing & Sterilization Market, 2018 - 2030 (USD Million)
5.2.5. Product Implementation
5.2.5.1. Product Implementation Market, 2018 - 2030 (USD Million)
5.2.6. Product Upgrade
5.2.6.1. Product Upgrade Market, 2018 - 2030 (USD Million)
5.2.7. Product Maintenance
5.2.7.1. Product Maintenance Market, 2018 - 2030 (USD Million)
5.2.8. Contract Manufacturing
5.2.8.1. Contract Manufacturing Market, 2018 - 2030 (USD Million)
Chapter 6. Inhaled and Intranasal Products Contract Service Providers Market: Regional Analysis
6.1. Inhaled and Intranasal Products Contract Service Providers: Regional market share analysis, 2022 & 2030
6.2. North America
6.2.1. North America Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.3.2. U.K.
6.3.2.1. U.K. Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.3.4. Italy
6.3.4.1. Italy Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.3.5. Spain
6.3.5.1. Spain Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.3.6. Denmark
6.3.6.1. Denmark Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030(USD Million)
6.3.7. Sweden
6.3.7.1. Sweden Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030(USD Million)
6.3.8. Norway
6.3.8.1. Norway Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030(USD Million)
6.3.9. Rest of EU
6.3.9.1. Rest of EU Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030(USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.4.2. China
6.4.2.1. China Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.4.3. India
6.4.3.1. India Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.4.4. Japan
6.4.4.1. Japan Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Australia Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.4.6. Thailand
6.4.6.1. Thailand Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.4.7. South Korea
6.4.7.1. South Korea Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.4.8. Rest of APAC
6.4.8.1. Rest of APAC Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Mexico Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.5.4. Argentina
6.5.4.1. Argentina Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.5.5. Rest of LATAM
6.5.5.1. Rest of LATAM Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.6. MEA
6.6.1. MEA Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. South Africa Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.6.3. South Arabia
6.6.3.1. South Africa Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. UAE Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Kuwait Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
6.6.6. Rest of MEA
6.6.6.1. Rest of MEA Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Inhaled and Intranasal Products Contract Service Providers: Company market share analysis, 2022 & 2030
7.2. Company Profiles
7.2.1. Lonza
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Service benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Catalent
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Service benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Kindeva Drug Delivery (Formerly 3M Drug Delivery Systems)
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Service benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Recipharma
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Service benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Quotient Services
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Service benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Hovione
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Service benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Colep
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Service benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Beximo Pharmaceuticals
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Service benchmarking
7.2.8.4. Strategic initiatives
7.2.9. DPT Laboratories
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Service benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Orion
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Service benchmarking
7.2.10.4. Strategic initiatives
List of Tables
Table 1 List of Secondary sources
Table 2 List of Abbreviations
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Volume price analysis
Fig. 9 Inhaled and Intranasal products contract service providers market snapshot (2022)
Fig. 10 Inhaled and Intranasal products contract service providers market segmentation
Fig. 11 Heat map analysis
Fig. 12 Parent market outlook
Fig. 13 Ancillary market outlook
Fig. 14 Penetration & growth prospect mapping
Fig. 15 Market driver relevance analysis (Current & future impact)
Fig. 16 Market restraint relevance analysis (Current & future impact)
Fig. 17 Porter’s five forces analysis
Fig. 18 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 19 Inhaled and Intranasal Products Contract Service Providers market drug delivery product outlook: Segment dashboard
Fig. 20 Inhaled and Intranasal Products Contract Service Providers market: drug delivery product movement analysis
Fig. 21 Metered- dose inhalers market, 2018 - 2030 (USD Million)
Fig. 22 Dry powder inhalers market, 2018 - 2030 (USD Million)
Fig. 23 Nebulizers market, 2018 - 2030 (USD Million)
Fig. 24 Others market, 2018 - 2030 (USD Million)
Fig. 25 Inhaled and Intranasal Products Contract Service Providers market services outlook: Segment dashboard
Fig. 26 Inhaled and Intranasal Products Contract Service Providers market: services movement analysis
Fig. 27 Quality Assurance market, 2018 - 2030 (USD Million)
Fig. 28 Regulatory Affair Services market, 2018 - 2030 (USD Million)
Fig. 29 Product Design & Development market, 2018 - 2030 (USD Million)
Fig. 30 Product Testing & Sterilization market, 2018 - 2030 (USD Million)
Fig. 31 Product Implementation market, 2018 - 2030 (USD Million)
Fig. 32 Product Upgrade market, 2018 - 2030 (USD Million)
Fig. 33 Product Maintenance market, 2018 - 2030 (USD Million)
Fig. 34 Contract Manufacturing market, 2018 - 2030 (USD Million)
Fig. 35 Regional market: Key takeaways
Fig. 36 Inhaled and Intranasal Products Contract Service Providers market: Regional movement analysis
Fig. 37 North America. market, 2018 - 2030 (USD Million)
Fig. 38 U.S. market, 2018 - 2030 (USD Million)
Fig. 39 Canada market, 2018 - 2030 (USD Million)
Fig. 40 Europe market, 2018 - 2030 (USD Million)
Fig. 41 U.K. market, 2018 - 2030 (USD Million)
Fig. 42 Germany market, 2018 - 2030 (USD Million)
Fig. 43 France market, 2018 - 2030 (USD Million)
Fig. 44 Italy market, 2018 - 2030 (USD Million)
Fig. 45 Spain market, 2018 - 2030 (USD Million)
Fig. 46 Denmark market, 2018 - 2030 (USD Million)
Fig. 47 Sweden market, 2018 - 2030 (USD Million)
Fig. 48 Norway market, 2018 - 2030 (USD Million)
Fig. 49 Rest of EU market, 2018 - 2030 (USD Million)
Fig. 50 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 51 Japan market, 2018 - 2030 (USD Million)
Fig. 52 China market, 2018 - 2030 (USD Million)
Fig. 53 India market, 2018 - 2030 (USD Million)
Fig. 54 Australia market, 2018 - 2030 (USD Million)
Fig. 55 Thailand market, 2018 - 2030 (USD Million)
Fig. 56 South Korea market, 2018 - 2030 (USD Million)
Fig. 57 Rest of APAC market, 2018 - 2030 (USD Million)
Fig. 58 Latin America market, 2018 - 2030 (USD Million)
Fig. 59 Brazil market, 2018 - 2030 (USD Million)
Fig. 60 Mexico market, 2018 - 2030 (USD Million)
Fig. 61 Argentina market, 2018 - 2030 (USD Million)
Fig. 62 Rest of LATAM market, 2018 - 2030 (USD Million)
Fig. 63 MEA market, 2018 - 2030 (USD Million)
Fig. 64 South Africa market, 2018 - 2030 (USD Million)
Fig. 65 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 66 UAE market, 2018 - 2030 (USD Million)
Fig. 67 Kuwait market, 2018 - 2030 (USD Million)
Fig. 68 Rest of MEA market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Lonza
  • Catalent
  • Kindeva Drug Delivery (Formerly 3M Drug Delivery Systems)
  • Recipharma
  • Quotient Services
  • Hovione
  • Colep
  • Beximo Pharmaceuticals
  • Dpt Laboratories
  • Orion

Methodology

Loading
LOADING...

Related Topics

Related Reports

Intranasal Drug and Vaccine Delivery Market Size, Share & Trends Analysis Report by Product, Dosage, Application, Distribution Channel, Region, and Segment Forecasts, 2025-2030 - Product Image

Intranasal Drug and Vaccine Delivery Market Size, Share & Trends Analysis Report by Product, Dosage, Application, Distribution Channel, Region, and Segment Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Intranasal Drug & Vaccine Delivery Market by Product, Dosage, Application, Distribution Channel - Global Forecast 2025-2030 - Product Image

Intranasal Drug & Vaccine Delivery Market by Product, Dosage, Application, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Intranasal Drug Delivery - Global Strategic Business Report - Product Image

Intranasal Drug Delivery - Global Strategic Business Report

  • Report
  • 459 Pages
  • Global
From
Intranasal Drug Delivery Devices Global Market Report 2024 - Product Image

Intranasal Drug Delivery Devices Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Intranasal Drug Delivery - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Intranasal Drug Delivery - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.